```markdown
{
"content": [
{
"type": "paragraph",
"content": "The Stelara market refers to the global industry for the medication Stelara, which is used to treat various autoimmune diseases. As a key player in the pharmaceutical industry, understanding the Stelara market size, growth outlook, market forecast, and industry expansion is crucial for executives and strategic planners. The scope of this market encompasses the treatment of plaque psoriasis, psoriatic arthritis, and Crohn's disease, among other conditions. The current Stelara market size is approximately $8.5 billion, with a growth forecast expecting a compound annual growth rate (CAGR) of around 6-7% from 2026 to 2033, driven by increasing demand for effective treatments and rising awareness about autoimmune diseases. Key forces shaping the industry include technology shifts, regulatory approvals, and changing consumer behavior."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Psoriasis", "Psoriatic Arthritis", "Crohn's Disease"],
"periods": ["2020", "2021", "2022", "2023", "2024","2025","2026","2027","2028","2029","2030","2031","2032"," "2033"],
"values": [
[1.2, 1.5, 1.8, 2.1, 2.4, 2.7, 3.0, 3.3, 3.6, 3.9, 4.2, 4.5, 4.8, 5.1],
[0.8, 0.9, 1.1, 1.3, 1.5, 1.7, 1.9, 2.1, 2.3, 2.5, 2.7, 2.9, 3.1, 3.3],
[0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8]
]
}
},
{
"type": "paragraph",
"content": "The largest region for the Stelara market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific, driven by increasing healthcare expenditure and rising awareness about autoimmune diseases. As the industry continues to evolve, it is essential for executives and strategic planners to stay informed about the latest trends and developments shaping the Stelara market."
}
]
}
```
